Medical Aesthetics Market | Allergan, Inc., Cynosure, Inc., Lumenis Ltd., Mentor Worldwide LLC, PhotoMedex, Inc., Galderma S.A. are leading Players

By -

Medical Aesthetics Market Product (Botox, Dermal Filler, Liposuction, Cellulite Reduction, Fat Reduction, Skin Tightening, Breast Implant, Tattoo Removal, Thread Lift), End User (Clinic, Medical Spa, Hospital, Beauty Center) - Global Forecast to 2023

(EMAILWIRE.COM, March 08, 2019 ) According to the new market research report “Medical Aesthetics Market Product (Botox, Dermal Filler, Liposuction, Cellulite Reduction, Fat Reduction, Skin Tightening, Breast Implant, Tattoo Removal, Thread Lift), End User (Clinic, Medical Spa, Hospital, Beauty Center) - Global Forecast to 2023", published by MarketsandMarkets™, The global medical aesthetics market is projected to reach USD 17.07 billion by 2023 from USD 10.30 billion in 2018, at a CAGR of 10.6%.

This market is divided into four major regions, namely, North America (U.S. and Canada), Europe (Germany, France, U.K. and Rest of Europe), Asia-Pacific, and the Rest of the World (RoW). Among these four regions, the Asia-Pacific market is projected to grow at the highest CAGR during the forecast period.

The medical aesthetics market is a diversified and competitive market with a large number of players. The product segments in the medical aesthetics market are dominated by various players, depending on their core competencies. In 2015, Allergan, Inc. dominated the global facial aesthetics and breast implants market. Moreover, in 2015, Syneron Medical Ltd. (Israel), Cynosure Inc. (U.S.), and Solta Medical Inc. (Canada), were the leading players in the energy-based devices market.

Read More @ https://www.marketsandmarkets.com/Market-Reports/medical-aesthetics-market-885.html

Allergan’s (U.S.) leadership position in the global facial and breast aesthetics market can be attributed to its broad product portfolio, strong geographical presence, and a wide customer base in the emerging economies, including Latin America, and Asia Pacific. In March 2015 Allergan, Inc. was acquired by Actavis plc, an Ireland based pharmaceutical company which helped Allergan, Inc. to be a division of a global pharmaceutical leader company and strengthened its distribution network.

In 2016, North America is expected to account for the largest share of the global medical aesthetics market, followed by Europe. The large share of this market is attributed to high number of aesthetic procedures performed in the region, developed healthcare system and presence of large number of medical aesthetic companies.

In the medical aesthetics market, leading players are adopting the strategies of new product launches; agreements, partnerships, and alliances; acquisitions, new product launches; and geographical expansion to augment their foot print’s in the market. Market players adopted these strategies to expand their product portfolios, enhance their geographic presence, and to increase their market shares.

Allergan, Inc. (Ireland), Cynosure, Inc. (U.S.), Lumenis Ltd. (Israel), Mentor Worldwide LLC (U.S.), PhotoMedex, Inc. (U.S.), Galderma S.A. (Switzerland), Solta Medical, Inc. (U.S), Syneron Medical, Ltd. (Israel), and ZELTIQ Aesthetics, Inc. (U.S.) are some of the key players in the global medical aesthetics market.

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve. 

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:

Mr. Shelly Singh

MarketsandMarkets™ INC.
630 Dundee Road

Suite 430

Northbrook, IL 60062

USA: 1-888-600-6441

Email: sales@marketsandmarkets.com

Media Contact

Read other news from MarketsandMarkets™

Timing Devices Market Size, Share, Revenue Trends & Forecast to 2030

MarketsandMarkets™ - Sep 18, 2023
Timing Devices Market by Type (Oscillators, Atomic Clocks, Clock Generators, Clock Buffers, Jitter Attenuators), Material (Crystal, Silicon, Ceramic), Vertical (Consumer Electronics, Automotive) and Region - Global Forecast to 2030 ...Read more

Artificial Intelligence Market Segmented by Product, Top Manufacturers, Geography Trends & Growth Opportunity to 2030

MarketsandMarkets™ - Sep 18, 2023
Artificial Intelligence technology such as machine learning, natural language processing, computer vision, and others are revolutionizing various sectors, including healthcare, finance, manufacturing, and retail. ...Read more

Digital PCR (dPCR) and Real-time PCR (qPCR) Market worth $12.4 billion by 2028, at a CAGR of 7.8%.

MarketsandMarkets™ - Sep 18, 2023
"Digital PCR (dPCR) and Real-time PCR (qPCR) Market by Product (Instruments, Reagents & Consumables, Software & Services), Application (Clinical, Research, Forensic), End User (Hospital, Diagnostic Labs, Pharma, Biotech, CROs) - Global Forecast to 2028". ...Read more